Page 2 of 2

Closed-Loop Marketing is simply not difficult

Closed-Loop Marketing, by David Hunt
Part II, a roadmap to success

Please first read Part I, Start and therefore finish with insight

map

It’s a well-trodden path, yet very few make it to the ambition – high value customer interactions that build long-term brand equity. What happens? Where does it all become too difficult? When do organisations default to the status-quo?

Below are five tips established through more than a decade’s experience of hits and misses (from which you tend to learn more, ask Google).

 

Is imagination more important than perspiration in the pursuit of CLM?
Of course not. It takes commitment, it takes expertise & it takes total belief across an organisation. But how do we ensure dedication? How do we engage exceptional talent? How do ensure buy-in? Through case studies – we’ve seen them. Through stats – we’ve heard them. Due to awards – big deal. You win by imagination, you win by inspiring your organisation, you win by conceptualising an experience that really will be exceptional.

Tip 1 – Lead with an idea, lead with a vision, lead with imagination.

 

“Hire people who are better than you are, then leave them to get on with it.”
David Ogilvy
The smartest people know to surround themselves with knowledge & expertise. I’m often amazed at individuals appetite for adventure, their brazen embrace of the unknown, and utter conviction in succeeding where others fail. It’s even more surprising when their qualifications are at odds with their latest challenge. Find someone with the t-shirt, someone with the battle scars, someone who knows how to succeed in CLM. Work with an expert, someone who can realise the ambition & become a catalyst for your success.

Tip 2 – To be the best, you need to work with the best.

 

The more you put in, the less they need to
Today we need almost instant gratification. We are spoilt in our interactions, and accept nothing less than an exceptional experience. As such the field demands an intuitive, flexible & rapid interface. The more we invest, the more 1% improvements we drive, the more we will engage the field, build their confidence and improve their performance. The more we do, the less they have to.

Tip 3 – The field force are your consumers, they need a consumer digital experience and not a pharma digital experience.

 

All platforms are equal, but some are more equal than others
I have never heard: “We’re really pleased with our platform, it’s exceeded all of our expectations!” Equally, I’ve never heard someone describe their OS, office software or email package as exceeding their expectations. Bizarre that whilst we are ambivalent to bugs from software power houses like Apple, we expect flawless solutions from software service providers to pharma. I’m not saying we should expect shoddy work, just that perspective will ensure we focus our efforts most appropriately. It’s easy to identify flaws in a platform, and easy to blame. Be brave and focus on the real issues limiting success.

Tip 4 – Remember it’s just a platform, and only part of the answer.

 

Perfection is enemy the enemy of good
In a digital world the best we can hope for is #FinalForNow. There will always be something new on the horizon. Waiting & wondering, standing on the side, reserving judgement – that’s easy. Being bold, seizing the initiative, capitalising now – is much more difficult. Guaranteed, in less than 12 months there’ll be better hardware, better software, more developed philosophies. Also guaranteed, the company that acted will be the company that leads.

Tip 5 – Don’t wait for the next technology push, it will always come round the corner.

 

 

A fresh start

It’s 5 years since the launch of the PM Society Digital Awards. In that time we’ve grown from 50 to 200, from local to global, digital to full-service,  from Creative Lynx to HAVAS LYNX.

There is no doubt that the PM Society Digital Awards created an essential platform for our success. They recognised & celebrated our creativity, passion & innovation. They challenged us to improve, and with 23 wins in 5 years, they ensured our exceptional standards were maintained.

However, for HAVAS LYNX it’s now time for a change, a fresh challenge, a new perspective. Instead of the PM Society Digital Awards, this year we’ve decided to enter the Cannes Lions Health awards.

It’s a global competition, derived from the most prestigious awards in advertising. Yet it also comes with unknowns; How will we do? Will we leave empty-handed? How expensive are the G&Ts in the South of France? More importantly, it comes with certainties; we’ve worked harder, pushed our ideas further, and we’ve challenged ourselves to be better.

HAVAS LYNX has a tremendous energy, and when under pressure we excel. We want to be pushed. And we want to be the best. This year we may not be successful, but we’ll be back again next year, better for the experience & even more determined. *fingers crossed*.

The PM Society Digital Awards are still a tremendous event, and I’ll certainly be supporting their team this year and in the future.growth

The death of traditional consumerism: what does it mean for pharma?

HAVAS Worldwide’s latest paper, The New Consumer & The Sharing Economy, outlines a growing sentiment against over consumption. Seven in ten of us believe it to be putting our society and the planet at risk, and the majority feel that current models of consumerism are not sustainable. More than this, we feel weighed down by the sheer amount of ‘stuff’ we own.

72983288

Put simply, we’re tired of consumerism and bored of adverts that try to manipulate us by pushing products at us like they’re the answer to life’s problems. We want to be in control, we want to be able to make informed decisions about how we spend our time and money and we don’t want others telling us what to do.

This goes for healthcare as much as consumer markets. Patients no longer expect to merely be prescribed a pill that they unwittingly swallow down once a day and hope for the best. Facilitated by an abundance of information technologies, they are knowledgeable about treatments and want to be actively involved in managing their own health care.

The wealth of monitoring apps across treatment areas (AsthmaCheck, MoodPanda and Diabetes In Check are but a few) is a fair indicator of a general desire for information and authority regarding personal treatment regimens. For financially hamstrung public health providers such as the NHS, this is a welcome trend. Empowering patients with greater control of their treatment reduces the burden of care placed on public providers, and has the potential to garner much better results by actively engaging patients.

So where does pharma fit into all this? The patent model and subsequent relationship with healthcare providers has always followed traditional models of consumerism; ‘we are a drug company and we’ve produced this drug which you can buy from us’. So how can we who work in pharma support and facilitate patients’ desires for greater inclusion and authority in their care and still turn a profit?

Firstly, we need to reshape our relationship with the people we serve. Pharmaceutical companies can no longer act as vendors and must become partners to professionals and patients alike. In doing so, we need to provide solutions, not pills, and increasingly this will mean delivering holistic services and systems of care. ‘Beyond the pill’ solutions are an arena in which there is massive potential for pharmaceutical companies to add real value.  At HAVAS LYNX we’ve worked on a series of patient care programmes that have been shown to half the number of days patients spend in hospital.

When pharma partners its expertise with other parties, it opens up a world of new revenue streams. Start-up accelerator organisations such as Healthbox are stimulating the sort of innovation and collaboration that pharma should be looking to more and more. Even amidst the context of Pfizer’s efforts to secure the acquisition of AstraZeneca, pharma companies need to look beyond traditional development pipelines when seeking to expand their offering.

We need to innovate past the sector mainstream and recognise outsider trends, much in the same way that Facebook is making moves to expand beyond social by purchasing of ProtoGeo. There are so many exciting and disruptive technologies being developed that have the potential to transform the lives of patients. Far more than offering supplementary revenue, these areas that currently lie on the fringes of the market are likely to be the mainstay of pharmaceuticals in the future.

 

LYNX London; What is the ambition for an agency start-up?

Agency expansion, by David Hunt

Emergence of a great team? High profile account wins? Excellent financial performance? Awards? 18 months in and HAVAS LYNX London have ticked every box.

The team is spread over two locations. I’m sure management consultants would describe it  as on-shoring and outline the benefits in cost efficiencies. Being very smart, they would also talk about even greater savings with alternate locations – quality is not everyone’s priority. Quality is LYNX London’s number one priority. We describe it as an agency, a modern agency, defined by expertise and not geography. Combining the creative & digital pedigree of Manchester, with the strategic and scientific expertise of London. We know the benefit is a best-in-class service.

HAVAS LYNX London
HAVAS LYNX London

The teams don’t share an office, rarely take lunch & have entirely different accents, yet they are tight knit & getting closer, creative & getting bolder, innovative & getting smarter. At the heart of their success are the people. From junior developers in Manchester through to account directors in London, the team is blessed with intelligence and drive.

The team that a client sees is important, but so too are the experts behind the scenes. Last year HAVAS LYNX London collected a number of high profiles accounts, through their exceptional service and high quality product. The team front-of-house and the guys in the kitchen aligned to the needs of the client. And fiercely determined too.

But it would be wrong to say it has all been easy, it has not. They have to make every communication count, but in a world when meetings are often bloated & ineffective perhaps this represents another strength. The creative leads are not just across the office, but equally they have few disruptions and an atypical opportunity to focus. Cultures are more difficult to align, but more rewarding when they do. Maybe it is harder, evidence would suggest it’s certainly worth it.

Since 2009 and a record award haul of 6 wins at the PM Digital Awards, HAVAS LYNX have had unprecedented success at industry events. Before that first glorious night, I remember attending countless events without success. As the saying goes, good things come to those that wait. It is with a slight twinge of jealousy, that LYNX London only had to wait 12 months to win their first significant gong – Digital Campaign at the PM Society Awards. Entirely deserved.

But their greatest achievement? Every member of the team contributing to a culture of success. From the top to the bottom, from the Manchester-based studio to the account team of London, from ping-pong to pitches, they want to win every time (and so far do).

10, 20, 50, 100 or 1,000; what’s the perfect size for an agency?

Client / Agency relationships, by David Hunt

178, the size of HAVAS LYNX. Ask anyone that manages an agency of 178 & they will say the same – it’s perfect. I imagine that in a few weeks 181 will be even more perfect. 

For years we were perceived as being too small. Now we are too big to be innovative, yet still too small to be a player?!? I disagree with both opinions.

Innovation & creativity is not about headcount. Never has been, never will be. It’s about people, passion & culture. With a background in digital, technology & creativity, I was appointed CEO at the age of 33. I’m driven by ideas & not numbers. Supported by a management team that believes in great work, we  now invest in more diverse expertise, try more unique technologies & chase more ideas than ever before. We are constantly looking for new concepts for ourselves, for our clients, for HCPs & for patients.

Can you be small, commercially motivated & technology agnostic? With the correct approach and the right people, perhaps. However, are you more likely to settle with the specialist you shared lunch with, or the unknown you still need to locate? With a big agency comes diverse expertise under one roof, providing seamless access to broad ideas. But can you be big & still bright? Certainly, but only by breaking down silos & embracing diversity. Different experiences, points of view & interests inspire innovation.

Like the story of Goldilocks, some agencies are too big, some agencies are too small, and some agencies are just right – it depends on your taste.

Three Bears
It is a matter of taste

Another strange question – do you have enough capacity? Does a prospective customer really want an agency that’s quiet? I’ve never walked into an empty restaurant, however if it’s heaving I want a reservation – evidence suggests that the product will be great. Do you want a partner that is free, or do you want a partner that is expert? A well run agency will have the infrastructure, process & connections to scale smartly and meet the fluid needs of their customers.

I’m proud to say that we are very big and we are very busy. And our clients choose HAVAS LYNX for our  ideas, innovation & ability to exceed expectations, and we are grateful for their patronage. 

Addressing the needs of pharmaceutical marketing and embracing 2014

2014, what are the strategic priorities for HAVAS LYNX? By David Hunt

Embracing 2014 and building on our strengths
Embracing 2014 and building on our strengths

Agency life is exciting, fluid & often unpredictable. I believe that the success of an agency depends on the team & the culture, and the ability they afford an agency to respond to change. However, whilst responding to the market, competitive landscape & technology is essential, so too is a bold strategy. As we embark on 2014, what are the strategic priorities for HAVAS LYNX?

People make an agency. Their talent, expertise & commitment deliver great campaigns, great innovation & great service. In 2014 we are launching the LX Academy to develop expertise & knowledge.

And it’s not just our people that shape our fortunes, the impact of good & bad clients is immeasurable. A good client values your opinion & respects your service. A bad client jeopardises your product, profitability & most importantly your people. In 2014 we will be as selective as our clients.

HAVAS LYNX Medical was launched in 2013. 2014 will be their year. Combining scientific expertise, digital innovation & ethics, they will provide unsurpassed medical education & scientific exchange. Led by Dr Nick Broughton, they will deliver significant ROI through smart, integrated campaigns that are defined by customers & not tradition.

The fantastic teams in LYNX London, LYNX Local & HAVAS HEALTH Software will continue to prosper & build on robust foundations. They are each unique & entirely designed around the needs of pharmaceutical marketing. LYNX London are shaping global strategies for Novartis, Janssen & Roche. In their fourth year, LYNX Local continue to ensure global campaigns have a local impact. And HAVAS HEALTH Software are a technology start-up that is redefining healthcare communications.

Founded in 1986 as Creative Lynx, HAVAS LYNX were driven by ideas & strategy. In the early noughties we embraced & defined digital in healthcare, but we never forgot our roots. As we move forward many of our clients partner with us for their strategy, ideas & innovations. Our ambition for 2014 is to continue this trend, delivering best-in-class campaigns that are defined by customer needs & not technology. 

Going Beyond The First Date, What it Takes to Win a Pitch

Agency Management; A good agency will still lose pitches, by David Hunt

You’ve had all the right signals; she laughs at your jokes, shows an interest in your stories, and your friend said – her friend said – that she said – she liked you. So why, when you asked her to the cinema, was she washing her hair? The life of an agency can at times, resemble those formative teen years. A lot of time, effort & dedication but without fair reward. To be successful there are three key ingredients – timing, chemistry & brilliance (I think you can win with two).

1st date

I’m busy tonight
Having graduated in Design in 2002, I found myself in Vancouver with Tim Woodcock, now GM of HAVAS LYNX London. I had a strong portfolio, excellent qualifications & the confidence of youth. With the help of the local design directory we set about securing employment. As a 22 year old, desperate for a job & a new life, I learnt more about pitching than at any other stage in my career. I’d know who I was meeting, their background, work, interests & ambitions. I’d know which of my portfolio would resonate the best, ideas they would get, reference they would love. The feedback was tremendous & disappointing in equal measure, “Love it!! But the timing…”, “Wow! But at the moment, we just can’t…”. In 2001, the burst of the dot.com bubble had ensured that the US investment had been withdrawn from Vancouver and local agencies were having to re-align their strategy & adopt a more cautious approach to recruitment. Despite, my best efforts there were simply not the opportunities. As I would learn throughout my career, even the most confident candidate, with their favourite ideas & best customer insight can be unsuccessful if the timing isn’t right.

It’s not you, it’s me
Without doubt our best campaigns are powered by chemistry when the client & agency teams work as one, from the medic through to engineer. Total alignment, a shared goal & a rewarding experience. Equally, at the heart of our more painful campaigns is a toxic relationship. A lack of empathy, trust and fragmented communication, will inevitably lead to a flawed deliverable. A defective relationship does not signal a bad agency, it simply confirms that as people – there are those we like & those we don’t. I applaud clients that make decisions based on their instinct, based on the people they meet and a conviction that they can collaborate. A campaign involves a long-term partnership, inevitably with highs & lows, so working with someone that you respect, whose opinion you value and company you enjoy, is a key ingredient for success. Even with perfect timing & great ideas – chemistry can be all important.

I’m just not sure
There are those agencies who believe life is a game of numbers, the more you ask, the more you get. They pitch more, but offer less. They don’t expose themselves, confident in the knowledge that they’ll win a couple. I COMPLETELY disagree. I have been brought-up to always give 110%. My Father-in-law, Carlo Distefano, owns an incredibly successful restaurant group and as he explains, “I work because I love it, and then it doesn’t feel like work”. You must be passionate about an opportunity, you must care about the outcome, you need to be your best. At the heart of every success is always a brilliant idea. It can be the right time and the right team, but without the excitement of an idea there is no vision. 

I ask three things of my teams at HAVAS LYNX:

  • Commit entirely to an opportunity, and deliver a brilliant idea
  • Understand the client, and build a partnership for success
  • Enjoy the creative process, as it just might not be your day

And like all the best relationships, the first date is just the beginning. Each & every day, we need to make our partners happy.